PKM and prostate carcinoma: Moreover, the lncRNA NORAD is highly expressed in prostate cancer cells and tissues and potentiates the secretion and uptake of prostate cancer EVs in recipient cells via regulating the miR-541-3p-pyruvate kinase M2 (PKM2) axis [42].